Lumos Pharma, Inc.
LUMO · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $25,902 | $30,229 | $57,758 | $242,040 |
| - Cash | $35,078 | $56,007 | $94,809 | $98,679 |
| + Debt | $585 | $233 | $557 | $319 |
| Enterprise Value | -$8,591 | -$25,545 | -$36,494 | $143,680 |
| Revenue | $2,051 | $1,523 | $230 | $168 |
| % Growth | 34.7% | 562.2% | 36.9% | – |
| Gross Profit | $2,051 | $1,474 | $230 | $168 |
| % Margin | 100% | 96.8% | 100% | 100% |
| EBITDA | -$36,570 | -$31,991 | -$31,130 | -$25,719 |
| % Margin | -1,783% | -2,100.5% | -13,534.8% | -15,308.9% |
| Net Income | -$34,034 | -$31,062 | -$30,430 | -$5,663 |
| % Margin | -1,659.4% | -2,039.5% | -13,230.4% | -3,370.8% |
| EPS Diluted | -4.18 | -3.71 | -3.65 | -0.84 |
| % Growth | -12.7% | -1.6% | -334.5% | – |
| Operating Cash Flow | -$31,095 | -$26,623 | -$29,648 | -$22,997 |
| Capital Expenditures | $0 | -$21 | -$30 | -$30 |
| Free Cash Flow | -$31,095 | -$26,644 | -$29,678 | -$23,027 |